{
  "id": 20135491,
  "updated": "2019-02-18T19:03:06Z",
  "additionalIndexing": "2841",
  "affairType": {
    "abbreviation": "Qst.",
    "id": 14,
    "name": "Heure des questions. Question"
  },
  "author": {
    "councillor": {
      "code": 2601,
      "gender": "f",
      "id": 1156,
      "name": "Heim Bea",
      "officialDenomination": "Heim"
    },
    "faction": {
      "abbreviation": "Groupe S",
      "id": 2,
      "name": "Groupe socialiste"
    },
    "type": "author"
  },
  "deposit": {
    "council": {
      "abbreviation": "CN",
      "id": 1,
      "name": "Conseil national",
      "type": "N"
    },
    "date": "2013-11-27T00:00:00Z",
    "legislativePeriod": 49,
    "session": "4911"
  },
  "descriptors": [
    {
      "key": "L04K01050110",
      "name": "Krebs",
      "type": 1
    },
    {
      "key": "L05K0105030104",
      "name": "Impfstoff",
      "type": 1
    },
    {
      "key": "L05K0806010102",
      "name": "Bewilligung",
      "type": 1
    },
    {
      "key": "L05K0107010301",
      "name": "Frau",
      "type": 1
    },
    {
      "key": "L04K01050510",
      "name": "Gesundheitsrisiko",
      "type": 1
    },
    {
      "key": "L06K010505070101",
      "name": "Impfung",
      "type": 2
    }
  ],
  "drafts": [
    {
      "consultation": {
        "resolutions": [

        ]
      },
      "federalCouncilProposal": {
      },
      "index": 0,
      "links": [

      ],
      "preConsultations": [

      ],
      "references": [

      ],
      "relatedDepartments": [
        {
          "abbreviation": "DFI",
          "id": 4,
          "name": "Département de l'intérieur",
          "leading": true
        }
      ],
      "states": [
        {
          "date": "/Date(1385506800000+0100)/",
          "id": 24,
          "name": "Non encore traité au conseil"
        },
        {
          "date": "/Date(1385938800000+0100)/",
          "id": 27,
          "name": "Liquidé"
        }
      ],
      "texts": [

      ]
    }
  ],
  "handling": {
    "date": "2013-12-02T00:00:00Z",
    "legislativePeriod": 49,
    "session": "4911"
  },
  "language": "fr",
  "relatedAffairs": [

  ],
  "roles": [
    {
      "councillor": {
        "code": 2601,
        "gender": "f",
        "id": 1156,
        "name": "Heim Bea",
        "officialDenomination": "Heim"
      },
      "faction": {
        "abbreviation": "Groupe S",
        "id": 2,
        "name": "Groupe socialiste"
      },
      "type": "author"
    }
  ],
  "shortId": "13.5491",
  "state": {
    "id": 27,
    "name": "Liquidé",
    "doneKey": "1",
    "newKey": 0
  },
  "texts": [
    {
      "type": {
        "id": 5,
        "name": "Texte déposé"
      },
      "value": "<p>Le vaccin Gardasil contre le cancer du col de l'utérus semble contesté depuis des années en raison d'effets secondaires possibles. Gardasil est disponible sur le marché en Suisse depuis novembre 2006.</p><p>- Combien d'annonces d'effets indésirables l'institut Swissmedic a-t-il reçu depuis lors?</p><p>- Ne faut-il pas selon lui vérifier l'autorisation de ce médicament?</p><p>- Dans l'affirmative, pourquoi exactement, et dans la négative, pourquoi pas?</p>"
    },
    {
      "type": {
        "id": 1,
        "name": "Titre de l'objet"
      },
      "value": "Vaccin Gardasil"
    }
  ],
  "title": "Vaccin Gardasil"
}